Novartis AG (NVS) — Business segments and KPIs
Revenue by business segment and geography for Novartis AG, with year-over-year trends.
FY 2022
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Top 20 products | 32.14B | 74.3% |
| Rest of portfolio | 9.16B | 21.2% |
| Total anti-infectives net sales | 1.20B | 2.8% |
| Anti Infectives sold under Sandoz name | 777M | 1.8% |
| Revenue by region | ||
| Other countries | 20.05B | 39.7% |
| UNITED STATES | 17.65B | 34.9% |
| GERMANY | 4.28B | 8.5% |
| CHINA | 3.13B | 6.2% |
| FRANCE | 2.26B | 4.5% |
| JAPAN | 2.21B | 4.4% |
| Country of domicile | 970M | 1.9% |